Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)

NCT00571753 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

900

Enrollment

OTHER

Sponsor class

Stopped Enrolling participants has halted prematurely due to a low recruitment rate.

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: isoniazid
DRUG: isoniazid

Sponsor

University of Cologne